Featured Posts

National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…

City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …
HeartLand Daily News
FDA Hid COVID Shot Side Effects—Congressional Report
Heartland Daily News cited CEI on COVID public health concerns Joel Zinberg, M.D., senior fellow at the Competitive Enterprise Institute and director of the Public…
Search Posts
Forbes
Gay Marriage, Polygamy, Bestiality, Abortion, Infanticide, Pot, Foie Gras, Plastic Bags, Big Gulps and Democracy
Consider the following list: 1) Marry someone of your same gender, 2) join a harem, 3) have sex with your donkey, 4) kill your baby the…
Bloomberg
Ignore Hysteria Over New ‘Monsanto’ Bill
Greg Conko, who studies biotech issues for the libertarian Competitive Enterprise Institute, points out that this fear is overblown, since organic standards require farmers to…
Forbes
FTC Drug Meddling Would Needlessly Push Pharmaceutical Costs Higher
Four of every five pharmaceutical prescriptions today are filled with a generic drug. That sounds like a big number, but the Federal Trade Commission (FTC)…
Heartlander
GMO Labeling to Appear on Washington Ballot
Gregory Conko, a senior fellow at the Competitive Enterprise Institute, says consumers have a right to know if products they purchase have negative health consequences.
News Release
Institute Welcomes Court Ruling on Commercial Free Speech
WASHINGTON, D.C., Dec. 4, 2012 – The Competitive Enterprise Institute applauded the U.S. Second Circuit Court of Appeals decision yesterday, concluding that the…
Hoover Institution
Free Speech for Big Pharma
One of the most important elements of medicine is also among the least well known: the ability of physicians to prescribe approved medicines for purposes…